Hepatitis C, An Appraisal of Percutaneous Treatment of Liver Metastases, Current Information On Hepatitis C & treatments for the medical professional and patient.

An Appraisal of Percutaneous Treatment of Liver Metastases


table 1. Data Summary of the Study Patients

Patient No.	Histotype	Total Diameter at Presentation (cm)	Ablation Treatment	No. of Sessions	Surgery Delay (mo)	Total Diameter at Surgery (cm)	Operation	Tumoral Necrosis	Follow-up, A/D (mo)

1	Colonic carcinoma	2	PEI	4	5	5	RH + DR	ND	D (14)
2	Leiomyosarcoma	3	PEI	2	8	8	RH	ND	A (19)
3	Colonic carcinoma	3.5	PEI	3	4	8	LL	ND	A (15)
4	Colonic carcinoma	2 + 2	PEI	4	7	5	RH + DR	ND	D (13)
5	Carcinoid	2.5^*	PEI/RF	21	18	2	2-Stage hepat + DR	80%	A (8)
6	Colonic carcinoma	2	RF	2	3	5	Bisegm + DR	<20%	A (8)
7	Carcinoid	2	RF	3	2	3	Wedge	50%	A (5)
8	Colonic carcinoma	3	RF	2	6	5	Wedge	<20%	A (3)

Abbreviations: RH, right hepatectomy; LH, left lobectomy; DR, diaphragmatic; ND, not determinable; A/D, alive/dead; 2-Stage hepat, right hepatectomy (plus diaphragmatic excision) followed by a left lobectomy 40 days later; Bisegm, bisegmentectomy. ^* Value expressed as mean.